BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10726337)

  • 1. The role of MRI in the surgical selection of cerebral metastases.
    Mastronardi L; Lunardi P; Puzzilli F; Schettini G; Lo Bianco F; Ruggeri A
    Zentralbl Neurochir; 1999; 60(3):141-5. PubMed ID: 10726337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI).
    Seute T; Leffers P; ten Velde GP; Twijnstra A
    Cancer; 2008 Apr; 112(8):1827-34. PubMed ID: 18311784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques.
    Paek SH; Audu PB; Sperling MR; Cho J; Andrews DW
    Neurosurgery; 2005 May; 56(5):1021-34; discussion 1021-34. PubMed ID: 15854250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.
    Zhou ZR; Shen TZ; Chen XR; Peng WJ
    Chin Med J (Engl); 2006 Mar; 119(6):467-73. PubMed ID: 16584644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.
    Barile A; Sabatini M; Iannessi F; Di Cesare E; Splendiani A; Calvisi V; Masciocchi C
    Radiol Med; 2004 Apr; 107(4):356-66. PubMed ID: 15103287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery.
    Truong MT; St Clair EG; Donahue BR; Rush SC; Miller DC; Formenti SC; Knopp EA; Han K; Golfinos JG
    Neurosurgery; 2006 Jul; 59(1):86-97; discussion 86-97. PubMed ID: 16823304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM; Ouyang H; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
    Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
    J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of the effectiveness of magnetic resonance imaging in delayed sequences after administration of Gd-DTPA contrast in the detection of metastatic lesions in the brain.
    Grzesiakowska U; Tacikowska M
    Med Sci Monit; 2002 Jan; 8(1):MT21-4. PubMed ID: 11782684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
    Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
    Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between noncontrast and contrast enhanced images.
    Thomson V; Pialat JB; Gay F; Coulon A; Voloch A; Granier A; Guérin JC; Viallon M; Berthezene Y
    Am J Clin Oncol; 2008 Jun; 31(3):285-92. PubMed ID: 18525309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
    Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine.
    Anzalone N; Gerevini S; Scotti R; Vezzulli P; Picozzi P
    Acta Radiol; 2009 Oct; 50(8):933-40. PubMed ID: 19626475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The usefulness of whole body FDG-PET/CT in patients with brain metastasis].
    Nakagawa K; Aoyagi M; Inaji M; Maehara T; Toriyama H; Kawano Y; Tamaki M; Nariai T; Ohno K
    No Shinkei Geka; 2009 Feb; 37(2):159-66. PubMed ID: 19227157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
    Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metastases in breast cancer: prognostic factors and management.
    Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
    Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
    Rockall AG; Planche K; Power N; Nowosinska E; Monson JP; Grossman AB; Reznek RH
    Neuroendocrinology; 2009; 89(3):288-95. PubMed ID: 19023191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of outcome in melanoma patients with cerebral metastases.
    Fife KM; Colman MH; Stevens GN; Firth IC; Moon D; Shannon KF; Harman R; Petersen-Schaefer K; Zacest AC; Besser M; Milton GW; McCarthy WH; Thompson JF
    J Clin Oncol; 2004 Apr; 22(7):1293-300. PubMed ID: 15051777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.